IndiTreat is supported by
The Danish Council for Strategic Research
The IndiTreat project aims at improving chemotherapeutic treatment of patients suffering from colorectal cancer. This is done through development and clinical validation of a new analysis method that can identify the best possible treatment for each patient.
The project is a collaboration between nanotechnologists, cell biologists, and medical doctors. The partners are DTU Nanotech (heading the project), Aarhus University, 2cureX, Bispebjerg Hospital, Rigshospitalet, and University of Colorado Cancer Center.
The total budget is 21 MDKK of which 16,4 MDKK are support from the Danish Council for Strategic Research.
The project will run for 4½ years and started on 1 January 2011.